← Browse entries

mkk-4

C. elegans

MAP kinase kinase mkk-4

What the model saw

Gene: mkk-4
Organism: Caenorhabditis elegans
Known functions: MAP kinase kinase mkk-4. ATP binding. MAP kinase kinase activity. mitogen-activated protein kinase kinase kinase binding. protein kinase activity. protein serine kinase activity. protein tyrosine kinase activity.
View unredacted entry
MAP kinase kinase mkk-4. ATP binding. MAP kinase kinase activity. mitogen-activated protein kinase kinase kinase binding. protein kinase activity. protein serine kinase activity. protein tyrosine kinase activity.

Solver output

Predicted influence
Anti-longevity
Confidence
65%
Mechanism
Cellular senescence
Reasoning

MKK-4 is a MAP kinase kinase (MAPKK) that functions in the stress-activated MAPK cascade, specifically as an activator of downstream MAP kinases such as PMK-1 (p38) or JNK-like kinases. In C. elegans, the MKK-4/SEK-1 axis feeds into the p38 MAPK pathway, which when chronically activated can promote stress-induced cellular damage responses and inflammatory-like signaling. While acute activation of stress MAPKs can be protective, constitutive or excessive MAPKK activity in this cascade is associated with pro-aging outcomes by driving cellular senescence-like states and suppressing DAF-16/FOXO-mediated longevity signaling. MKK-4's dual serine and tyrosine kinase activity (characteristic of MAPKKs) places it upstream of stress kinase cascades that, when persistently active, antagonize the insulin/IGF-1 longevity pathway. Additionally, JNK pathway activation via MKK-4 can phosphorylate and inhibit DAF-16 nuclear localization, reducing expression of longevity-promoting target genes.

Key pathways
p38/JNK MAPK stress signaling cascadeDAF-16/FOXO transcription factor regulationinsulin/IGF-1 longevity pathway antagonism
Longevity influence
Anti-longevity
Lifespan effect
Decrease

GenAge curators classify each gene's normal function as promoting (Pro-Longevity) or opposing (Anti-Longevity) longevity, based on synthesis across studies. Loss-of-function effects can vary from this depending on the manipulation.

Advisor judgment

Answer
Correct
Mechanism
Incorrect
Reasoning quality
2/5
Failure mode
Right answer, wrong reasoning
Notes

The model correctly predicts anti_longevity for mkk-4, but the mechanistic reasoning is problematic. The model invokes "cellular senescence" as the mechanism class, which is not a well-established concept in C. elegans biology. More critically, the reasoning conflates MKK-4's role: it claims JNK pathway activation via MKK-4 inhibits DAF-16 nuclear localization, but in C. elegans, JNK (JNK-1) signaling actually promotes DAF-16 nuclear localization and longevity — the opposite of what the model states. The model's reasoning about MKK-4 being anti-longevity through DAF-16 inhibition is mechanistically backwards for the JNK pathway. MKK-4 in C. elegans is known to activate SEK-1 and downstream stress kinases; its anti-longevity role is more likely related to its role in stress signaling pathways that when disrupted (loss of function) extend lifespan, but the model's specific mechanistic claims about DAF-16 inhibition via JNK are incorrect. The confidence of 0.65 is reasonable given the uncertainty, but the mechanistic explanation contains significant errors.

Raw API responses

solver

{
  "reasoning": "MKK-4 is a MAP kinase kinase (MAPKK) that functions in the stress-activated MAPK cascade, specifically as an activator of downstream MAP kinases such as PMK-1 (p38) or JNK-like kinases. In C. elegans, the MKK-4/SEK-1 axis feeds into the p38 MAPK pathway, which when chronically activated can promote stress-induced cellular damage responses and inflammatory-like signaling. While acute activation of stress MAPKs can be protective, constitutive or excessive MAPKK activity in this cascade is associated with pro-aging outcomes by driving cellular senescence-like states and suppressing DAF-16/FOXO-mediated longevity signaling. MKK-4's dual serine and tyrosine kinase activity (characteristic of MAPKKs) places it upstream of stress kinase cascades that, when persistently active, antagonize the insulin/IGF-1 longevity pathway. Additionally, JNK pathway activation via MKK-4 can phosphorylate and inhibit DAF-16 nuclear localization, reducing expression of longevity-promoting target genes.",
  "confidence": 0.65,
  "key_pathways": [
    "p38/JNK MAPK stress signaling cascade",
    "DAF-16/FOXO transcription factor regulation",
    "insulin/IGF-1 longevity pathway antagonism"
  ],
  "mechanism_class": "cellular_senescence",
  "longevity_influence": "anti_longevity"
}

advisor

{
  "notes": "The model correctly predicts anti_longevity for mkk-4, but the mechanistic reasoning is problematic. The model invokes \"cellular senescence\" as the mechanism class, which is not a well-established concept in C. elegans biology. More critically, the reasoning conflates MKK-4's role: it claims JNK pathway activation via MKK-4 inhibits DAF-16 nuclear localization, but in C. elegans, JNK (JNK-1) signaling actually promotes DAF-16 nuclear localization and longevity — the opposite of what the model states. The model's reasoning about MKK-4 being anti-longevity through DAF-16 inhibition is mechanistically backwards for the JNK pathway. MKK-4 in C. elegans is known to activate SEK-1 and downstream stress kinases; its anti-longevity role is more likely related to its role in stress signaling pathways that when disrupted (loss of function) extend lifespan, but the model's specific mechanistic claims about DAF-16 inhibition via JNK are incorrect. The confidence of 0.65 is reasonable given the uncertainty, but the mechanistic explanation contains significant errors.",
  "failure_mode": "right_answer_wrong_reasoning",
  "answer_correct": true,
  "mechanism_correct": false,
  "reasoning_quality": 2,
  "ground_truth_questionable": false
}